# CAE Inc: financial statements, quarterly

CAE · Nasdaq · CIK 1173382 · [Technology](/sectors/technology.md)

Pages: [Overview](/companies/cae.md) · [Financials](/companies/cae/financials.md) · [Filings](/companies/cae/filings.md) · [Insiders](/companies/cae/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cae/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-03-31) | period not labelled (2017-03-31) | FY2018 (2018-03-31) | FY2019 (2019-03-31) | FY2020 (2020-03-31) | FY2021 (2021-03-31) | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001173382-18-000021.md) | [0.5](/filings/0001173382-19-000015.md) | [0.6](/filings/0001173382-20-000018.md) | [0.4](/filings/0001173382-21-000021.md) | [0.9](/filings/0001173382-22-000017.md) | [0.9](/filings/0001173382-23-000022.md) | [0.3](/filings/0001173382-24-000023.md) | [0.2](/filings/0001173382-25-000029.md) | [0.2](/filings/0001173382-25-000029.md) | [0.3](/filings/0001173382-25-000029.md) |
| Current assets | $bn | not reported | [2.0](/filings/0001173382-19-000015.md) | [2.1](/filings/0001173382-19-000015.md) | [2.1](/filings/0001173382-20-000018.md) | [2.8](/filings/0001173382-21-000021.md) | [3.4](/filings/0001173382-22-000017.md) | [2.1](/filings/0001173382-23-000022.md) | [2.2](/filings/0001173382-24-000023.md) | [2.0](/filings/0001173382-25-000029.md) | [2.1](/filings/0001173382-25-000029.md) |
| Total assets | $bn | not reported | [5.4](/filings/0001173382-19-000015.md) | [5.8](/filings/0001173382-19-000015.md) | [7.2](/filings/0001173382-20-000018.md) | [8.5](/filings/0001173382-21-000021.md) | [8.7](/filings/0001173382-22-000017.md) | [9.6](/filings/0001173382-23-000022.md) | [10.4](/filings/0001173382-24-000023.md) | [9.8](/filings/0001173382-25-000029.md) | [11.2](/filings/0001173382-25-000029.md) |
| Current liabilities | $bn | not reported | [1.4](/filings/0001173382-19-000015.md) | [1.5](/filings/0001173382-19-000015.md) | [1.9](/filings/0001173382-20-000018.md) | [2.1](/filings/0001173382-21-000021.md) | [2.6](/filings/0001173382-22-000017.md) | [2.1](/filings/0001173382-23-000022.md) | [2.2](/filings/0001173382-24-000023.md) | [2.4](/filings/0001173382-25-000029.md) | [2.7](/filings/0001173382-25-000029.md) |
| Total liabilities | $bn | not reported | [3.4](/filings/0001173382-19-000015.md) | [3.5](/filings/0001173382-19-000015.md) | [4.8](/filings/0001173382-20-000018.md) | [5.9](/filings/0001173382-21-000021.md) | [5.5](/filings/0001173382-22-000017.md) | [5.5](/filings/0001173382-23-000022.md) | [5.8](/filings/0001173382-24-000023.md) | [5.5](/filings/0001173382-25-000029.md) | [6.2](/filings/0001173382-25-000029.md) |
| Shareholders' equity | $bn | [1.9](/filings/0001173382-18-000021.md) | [2.0](/filings/0001173382-19-000015.md) | [2.2](/filings/0001173382-19-000015.md) | [2.3](/filings/0001173382-20-000018.md) | [2.5](/filings/0001173382-21-000021.md) | [3.1](/filings/0001173382-22-000017.md) | [4.0](/filings/0001173382-23-000022.md) | [4.5](/filings/0001173382-24-000023.md) | [4.2](/filings/0001173382-25-000029.md) | [4.9](/filings/0001173382-25-000029.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 320,265,108 at 2025-03-31, from the cover of the [40-F filed 2025-06-20](/filings/0001173382-25-000029.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.